C21 Investments Inc CXXIF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CXXIF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.31
- Day Range
- $0.28–0.33
- 52-Week Range
- $0.20–0.47
- Bid/Ask
- $0.26 / $0.34
- Market Cap
- $33.84 Mil
- Volume/Avg
- 17,640 / 55,638
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.20
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 142
- Website
- https://www.cxxi.ca
Valuation
|
Metric
|
CXXIF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.04 |
Price/Sales | 1.20 |
Price/Cash Flow | 28.61 |
Price/Earnings
CXXIF
Financial Strength
|
Metric
|
CXXIF
|
|---|---|
Quick Ratio | 0.17 |
Current Ratio | 0.53 |
Interest Coverage | −0.21 |
Quick Ratio
CXXIF
Profitability
|
Metric
|
CXXIF
|
|---|---|
Return on Assets (Normalized) | −3.97% |
Return on Equity (Normalized) | −6.73% |
Return on Invested Capital (Normalized) | −4.82% |
Return on Assets
CXXIF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Xpnnsygb | Jbwfygk | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Wgmknvkdj | Trdgx | $68.9 Bil | |
HLN
| Haleon PLC ADR | Rdfdnyrh | Jmldy | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Hzkhksb | Krzhw | $14.8 Bil | |
VTRS
| Viatris Inc | Dpkhwqfg | Qbs | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Nknzxdj | Qxbw | $11.9 Bil | |
CTLT
| Catalent Inc | Xwtlcmlyv | Yndczv | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Sprlwbs | Znt | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Ypkmxxwb | Zvssk | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Mknszblp | Psknkl | $3.5 Bil |